Loading...
XHKG
3613
Market cap974mUSD
Dec 05, Last price  
9.06HKD
1D
1.12%
1Q
0.33%
Jan 2017
-13.55%
IPO
13.96%
Name

Beijing Tong Ren Tang Chinese Medicine Co Ltd

Chart & Performance

D1W1MN
XHKG:3613 chart
P/E
15.16
P/S
4.71
EPS
0.60
Div Yield, %
7.28%
Shrs. gr., 5y
Rev. gr., 5y
2.38%
Revenues
1.61b
+5.69%
333,039,000613,963,000761,051,000970,477,0001,084,280,0001,265,994,0001,513,873,0001,432,632,0001,315,346,0001,556,158,0001,731,095,0001,524,945,0001,611,644,000
Net income
500m
-7.42%
155,935,000220,001,000287,124,000354,249,000420,315,000489,967,000580,720,000556,118,000542,456,000607,838,000645,875,000540,393,000500,278,000
CFO
-217m
L
185,096,000142,528,000244,734,000353,576,000467,721,000469,144,000577,684,000551,010,000116,054,000777,170,000547,444,000460,831,000-217,251,000
Dividend
Jun 12, 20240.33 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 23 retail outlets in Hong Kong and 46 retail outlets in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
IPO date
May 07, 2013
Employees
789
Domiciled in
HK
Incorporated in
HK

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT